Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/8272
Title: Voltammetric Behavior of Antileukemia Drug Glivec. Part III: In Situ DNA Oxidative Damage by the Glivec Electrochemical Metabolite
Authors: Diculescu, Victor Constantin 
Vivan, Marilene 
Brett, Ana Maria Oliveira 
Issue Date: 2006
Citation: Electroanalysis. 18:19-20 (2006) 1963-1970
Abstract: Glivec is a relatively small molecule with activity against the protein tyrosine kinase, a protein expressed by all patients with chronic myelogenous leukemia (CML). Based on its activity on CML, glivec is undergoing extensive evaluation of its activity against other types of tumor. As a result, there is an ongoing need for clarification of glivec pharmacokinetics so that issues such as drug-biomolecular complex interactions can be understood.
URI: http://hdl.handle.net/10316/8272
DOI: 10.1002/elan.200603602
Rights: openAccess
Appears in Collections:FCTUC Química - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
obra.pdf121.53 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

29
checked on Feb 18, 2020

WEB OF SCIENCETM
Citations 5

26
checked on Dec 2, 2021

Page view(s)

199
checked on Nov 24, 2021

Download(s)

198
checked on Nov 24, 2021

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.